Caricamento...
Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives
BACKGROUND: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. To ensure the quality and safety of plasma-derived products, European regulations, Plasma Protein Therapeutics Association (PPTA) standard and FDA guidelines require testing of manufactu...
Salvato in:
| Pubblicato in: | Virol J |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596515/ https://ncbi.nlm.nih.gov/pubmed/26445095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-015-0396-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|